Table 2.
Comparison of general data of patients.
| Project | Content | A (n = 168) | B (n = 169) | P |
|---|---|---|---|---|
| Age | Year | 57.23 ± 8.96 | 51.61 ± 10.24 | 0.718 |
|
| ||||
| Gender | Male | 109 (64.8%) | 110 (65.3%) | 0.969 |
| Female | 59 (35.2%) | 59 (34.8%) | — | |
|
| ||||
| Pathology | Adenocarcinoma | 100 (59.6%) | 113 (66.7%) | 0.164 |
| Squamous cell carcinoma | 68 (41.4%) | 56 (33.3%) | ||
|
| ||||
| Basic diseases | Hypertension | 34 (20.5%) | 28 (18.5%) | 0.836 |
| Coronary heart disease | 16 (9.3%) | 21 (13.5%) | ||
| Diabetes | 21 (12.3%) | 18 (11.4%) | ||
|
| ||||
| Lesion location | Upper lobe of the right lung | 45 (26.5%) | 61 (36.3%) | 0.055 |
| Middle lobe of the right lung | 12 (7.3%) | 11 (6.6%) | ||
| Right inferior lobe of the lung | 45 (26.5%) | 34 (20.2%) | ||
| Upper lobe of the left lung | 32 (19.1%) | 43 (25.5%) | ||
| Left inferior lobe of the lung | 34 (20.3%) | 20 (11.9%) | ||
|
| ||||
| Pathological stage | IA | 36 (21.2%) | 34 (20.3%) | 0.882 |
| IB | 43 (25.3%) | 39 (23.3%) | ||
| IIA | 30 (17.6%) | 37 (21.7%) | ||
| IIB | 32 (19.3%) | 30 (17.8%) | ||
| IIIA | 27 (16.3%) | 29 (17.3%) | ||